These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Regulation of the Warburg effect in early-passage breast cancer cells. Robey IF; Stephen RM; Brown KS; Baggett BK; Gatenby RA; Gillies RJ Neoplasia; 2008 Aug; 10(8):745-56. PubMed ID: 18670636 [TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
26. Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells. Kaushik N; Lee SJ; Choi TG; Baik KY; Uhm HS; Kim CH; Kaushik NK; Choi EH Sci Rep; 2015 Mar; 5():8726. PubMed ID: 25735798 [TBL] [Abstract][Full Text] [Related]
27. Protein kinase D1 regulates hypoxic metabolism through HIF-1α and glycolytic enzymes incancer cells. Chen J; Cui B; Fan Y; Li X; Li Q; Du Y; Feng Y; Zhang P Oncol Rep; 2018 Aug; 40(2):1073-1082. PubMed ID: 29901206 [TBL] [Abstract][Full Text] [Related]
28. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma. Nakajima K; Kawashima I; Koshiisi M; Kumagai T; Suzuki M; Suzuki J; Mitsumori T; Kirito K Exp Hematol; 2019 Oct; 78():46-55.e3. PubMed ID: 31560931 [TBL] [Abstract][Full Text] [Related]
29. Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis. Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S Tumour Biol; 2016 Sep; 37(9):12347-12358. PubMed ID: 27306214 [TBL] [Abstract][Full Text] [Related]
30. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions. Xia T; Cheng H; Zhu Y Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051 [TBL] [Abstract][Full Text] [Related]
32. Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols. Hong KS; Park JI; Kim MJ; Kim HB; Lee JW; Dao TT; Oh WK; Kang CD; Kim SH Toxicol Appl Pharmacol; 2012 Mar; 259(2):210-8. PubMed ID: 22245592 [TBL] [Abstract][Full Text] [Related]
33. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386 [TBL] [Abstract][Full Text] [Related]
34. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas. Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290 [TBL] [Abstract][Full Text] [Related]
35. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114 [TBL] [Abstract][Full Text] [Related]
36. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. Koshiji M; Kageyama Y; Pete EA; Horikawa I; Barrett JC; Huang LE EMBO J; 2004 May; 23(9):1949-56. PubMed ID: 15071503 [TBL] [Abstract][Full Text] [Related]
37. Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells. Huang SW; Kao JK; Wu CY; Wang ST; Lee HC; Liang SM; Chen YJ; Shieh JJ Oncotarget; 2014 Mar; 5(5):1363-81. PubMed ID: 24658058 [TBL] [Abstract][Full Text] [Related]
38. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors. Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583 [TBL] [Abstract][Full Text] [Related]
39. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493 [TBL] [Abstract][Full Text] [Related]
40. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways. Kumar S; Donti TR; Agnihotri N; Mehta K Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]